Clinical trial
COPD on Primary Care Treatment (COOPT)
NCT00184977 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00184977 |
|---|---|
| Title | COPD on Primary Care Treatment (COOPT) |
| Official title | A Double-blind Placebo-controlled Trial Comparing the Efficacy and Cost-effectiveness of Inhaled Fluticason Propionate Versus Oral N-acetylcysteine in the Treatment of Patients With COPD in General Practice |
| Lead sponsor | Radboud University Medical Center, Other |
| Collaborators | Dutch Health Care Insurance Board (CVZ) GlaxoSmithKline Industry Zambon SpA The Netherlands Asthma Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive, Bronchitis, Chronic |
| Intervention type | Drug |
| Interventions | N-acetylcysteine, fluticasone propionate |
| Enrollment | 270 |
| Start date | Dec 1, 1998 |
| Completion | Jan 1, 2003 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 12, 2010 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: